Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
Recently at CRT21, Dr. Matthew Price, Director of the Cardiac Catheterization Laboratory at Scripps Clinic in La Jolla, presented the first sub-analysis of the Disrupt CAD III U.S. pivotal study, looking at clinical outcomes with IVL in lesions <25mm compared to those with ≥25mm. After his presentation, we caught up with Dr. Price to get his perspective on the data and its significance. You can also watch his full presentation at the video below.
Following the recent PMA approval of coronary IVL, Dr. Robert Riley, Medical Director of the Complex Coronary Therapeutics Program, and Dr. John Corl, Medical Director of PAD/CLI Program, of the Christ Hospital in Cincinnati, performed the first commercial U.S. coronary IVL cases. Following their cases, we caught up with Dr. Riley to get his take on using the technology outside of a clinical trial and what advice he has for other physicians before they try the technology.
Topics: Coronary IVL, Shockwave C2
Your first Shockwave IVL newsletter, PulsePoint, has arrived. We’re kicking off with an ambitious recap of 2020, celebrating key milestones and major events for our customers using our peripheral technology across the globe. Released on a quarterly basis moving forward, PulsePoint will be the one stop shop for all the latest news and updates throughout the year. We hope you enjoy our first global edition of PulsePoint.
Topics: Peripheral IVL, PulsePoint Newsletter
The treatment of calcified below-the-knee (BTK) lesions is challenging, associated with sub-optimal procedural outcomes, resulting in early recoil, and may contribute to restenosis.
Topics: Peripheral IVL, Peripheral Clinical Data
In case you missed its live airing, tune into a great discussion from coronary IVL’s most knowledgeable operators about how they are treating severely calcified lesions, their tips and tricks using IVL in real world practice as well as their clinical experience with IVL.
Topics: Coronary Clinical Data, Shockwave C2
Following the excitement of the PAD III RCT results presented at VIVA in November, a rock star faculty of Prof. Gunnar Tepe, Prof. Thomas Zeller, Dr. Arne Schwindt and Dr. Lorenzo Patrone assembled for an incathlab session to discuss the study results and how IVL offers superior vessel preparation over conventional PTA in severely calcified PAD lesions.
Topics: Peripheral IVL, Peripheral Clinical Data
If an image is worth a thousand words, then we’d have to write a novel to capture all of the key takeaways from the 300 OCT images (i.e. pre-IVL, post-IVL & post-DES) that were taken from the 100 patients that participated in the Disrupt CAD III OCT sub-analysis. Thankfully, we ditched the novel and opted for an easy-to-digest infographic to capture the 10 most pertinent data points from the OCT study presented at TCT Connect. Happy viewing!
Topics: Coronary Clinical Data, Shockwave C2, Treating Different Ca++ Morphologies
Eccentric calcium has always been a ‘pain’…a real thorn in the interventionalists’ side. While current devices in eccentric calcium often expand the healthy, non-calcified side of the artery or fall subject to wire bias that prevents it from reaching the calcified side of the artery, coronary Intravascular Lithotripsy (IVL) offers a new alternative that can modify both concentric and eccentric calcium equally as well. Don’t be satisfied with less than ideal stent expansion in eccentric calcium, instead learn how Dr. Margaret McEntegart has used IVL to modify eccentric calcium in the left main and hear Profs. Holger Nef & Carlo Di Mario share their recent publications and clinical data comparing IVL outcomes in eccentric and concentric calcified lesions.
Assessment and Management of Calcified Coronary Lesions, Part 1/5
Live in a Box: Left Main Bifurcation Lesion with Eccentric Calcium, Part 2/5
CAD I/II Analysis: Eccentric Vs. Concentric Lesions, Part 3/5
Lithotripsy in Eccentric and Concentric Coronary Calcifications, Part 4/5
Discussion and Conclusion, Part 5/5
Topics: Coronary Clinical Data, Shockwave C2, Treating Different Ca++ Morphologies
Dr. Sandeep Basavarajaiah, consultant cardiologist at Heartlands Hospital in Birmingham, UK, and other leading UK and Italian cardiologists published their initial real-world experience with Intravascular Lithotripsy (IVL) in a real-world population, in Catheter Cardiovasc Interv: “Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study”.
Topics: Coronary IVL, Coronary Clinical Data, Shockwave C2
At the recent PCR Valves eCourse (aka London Valves), an esteemed faculty reported on the use of IVL- facilitated TAVI. Profs./Drs. Carlo Di Mario, Ole De Backer, Joachim Schofer, Constantin von zur Mühlen used published data and case experiences to illustrate the advantages of using IVL to maintain transfemoral access in TAVI patients with severely calcified iliacs. Considering the importance of reducing complications to minimize hospital stay, the faculty expressed enthusiasm when considering the use of IVL in these very complex patients. Happy viewing!
Topics: Peripheral IVL, Peripheral Clinical Data
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
